Top Pharma Blogs
Share the Top Pharma Blogs on
Pharma 2.0
In the past I have written about drug review sites like iGuard.org. Social/digital pharma blogger extraordinaire Jon Richman recently wrote a post about “The Best Pharma Products According to Patients” on Dose of Digital. He provides deep analysis about iGuard in particular which has over 2 million users...
I do not know Bertalan Mesko, MD personally but this Hungarian physician and PhD-to-be in personalized genomics publishes some of the best content related to Health 2.0 on the Web. His blog is ScienceRoll and he tweets @berci. Bertalan has assembled an incredible list of online/2.0 resources by specialty on his...
My friend and fellow social media evangelist Eileen O’Brien has launched a weekly Tweetchat about social media and pharma. I stumbled upon it on Wednesday night (1/6) and joined in near the end when Eileen mentioned AZ Helps – a sort of help desk offering from AstraZeneca that uses...
Pharma and Healthcare Social Media Wiki
I have no clue when Jonathan Richman has time to sleep or work given all of the information he gathers and publishes on his blog Dose of Digital. One of the best areas on his site is the Pharma and Healthcare Social Media Wiki. It is chock full of real-world...
Facts, figures, data. We all love to use numbers in our PPTs. Great info has trickled out over the past couple of months from one of my favorite sources – Manhattan Research. And thank you to MR for mentioning Pharma 2.0 in its white paper: How Digital is Shaping...
FDA hearings on social media in progress
The day has arrived – the big FDA hearings on social media. People are tweeting and blogging and texting and posting every single word of the testimony. It is surreal and exhausting to follow, which I only do sporadically. There will so many post-mortems on the two days I...
Pharmainfo.net - Pharma Industry News
No early return seen for Teva chairman Hurvitz
No early return seen for Teva chairman Hurvitz Globes - 17 minutes ago Company sources deny rumors that Phillip Frost seeks to replace Eli Hurvitz and move Teva's HQ to the US. 20 days ago, , Teva Pharmaceutical Industries Ltd. (Nasdaq: TEVA; TASE: TEVA) announced ... ...
Pfizer woos Ratiopharm with ramp-up pledge -sources
Pfizer woos Ratiopharm with ramp-up pledge -sources Reuters - 17 minutes ago By Frank Siebelt FRANKFURT, March 7 (Reuters) - Pfizer Inc (PFE.N) wheeled out its chief executive and pledged to invest in growth as it sought to win the bidding to buy German generic drugmaker ... ...
Merck sues Teva over cholesterol drug
Merck sues Teva over cholesterol drug Globes - 22 minutes ago Merck & Co. (NYSE: MRK) last week sued Teva Pharmaceutical Industries Ltd. (Nasdaq: TEVA; TASE: TEVA) to prevent it from selling a generic version of the cholesterol drug Vytorin in the US. Teva ... ...
Jonathan Suter Named to Exclusive Membership Organization
Jonathan Suter Named to Exclusive Membership Organization PR-CANADA.net - 3 minutes ago Jonathan Suter, Manager at Bristol-Myers Squibb, has been recognized by Cambridge Who's Who for demonstrating dedication, leadership and excellence in his field of business. After working in ... ...
A roadmap for the next set of reforms
A roadmap for the next set of reforms istockAnalyst.com - 30 minutes ago Mar. 6, 2010 (The Hindu Business Line) -- Umang Vohra The Union Budget was delivered as expected – Fiscally prudent and responsive, and rightfully addressing the most-pressing needs of the moment ... ...
HAYWARD, Calif., March 6 /PRNewswire/ -- Acologix, Inc., a privately held biopharmaceutical company, today announced the results of its latest preclinical study demonstrating that AC-100, its therapeutic product candidate derived from an endogenous human protein, promotes cartilage regeneration in a ...
BioSpace.com Featured News and Stories
New Daiichi Sankyo, Inc. Inhaled Drug Protects from Flu in Single Dose
Reuters -- A single dose of an experimental influenza drug saves more mice from H5N1 avian influenza than the preferred drug Tamiflu, researchers reported on Thursday, and can also protect against infection....
San Jose State University (SJSU) Receives $5 Million To Boost Biotech Jobs
var addthis_pub"bdwyer";...
Zeltia Biopharmaceutical Revenues up 53.3%
MADRID, Spain, Feb. 25 /PRNewswire/ -- Consolidated revenues for Zeltia (ZEL.MC) amounted to 123.4 million euro (an estimated 166.29 million USD) in 2009, up 17.2% with respect to 2008. Net income improved by 36.3%. Biopharmaceutical revenues expanded 53.3% due primarily to sales of Yondelis(R), which totaled 44.12 million euro (approximately...
Reuters -- Two Canadian drugmakers, Biovail Corp and Labopharm Inc, said on Thursday they plan to spend more on new drug launches this year as they reported quarterly results....
Drug Makers Tap Into "Peer-influence Marketing"
WSJ -- Who are you going to listen to when it comes to medicinesyour peers or the companies that actually make the drugs? Market research shows that the sick are relying more on the recommendations of fellow patients, and less on the reputations of companies and endorsers, in deciding...
Vitamin B3 Shows Early Promise in Treatment of Stroke, Henry Ford Hospital Study
var addthis_pub"bdwyer";...
Bristol aims for five new meds by 2012
Bristol-Myers Squibb says it plans to introduce five new drugs, including treatments for cancer, diabetes and heart disease, by 2012, as its top-selling medicine, the blood-thinner Plavix, loses patent protection. Report...
Few pharmas to profit off CV growth
The market for cardiovascular drugs will grow by $8 billion by 2018, but that doesn't mean drugmakers will necessarily profit. A Datamonitor study finds that because major CV meds are going off patent, generics will play a growing role in treating cardiac disease, making a big dent in Big Pharma's...
Merck to appeal Aussie Vioxx ruling
An Australian court held Merck liable for the heart attack suffered by a patient using its now-withdrawn painkiller Vioxx. The federal judge ruled that Vioxx was defective and ordered the drugmaker's Australian unit to pay about $260,000 in compensation to the patient, Graeme Peterson. Vioxx almost doubled the risk of a...
Pfizer tops in DTC spending with $1.1B
Has pharma's DTC spending bottomed out? If you look at the trend line over the past few years, it appears so. Last year, consumer ad spending rose by 1.9 percent to $4.5 billion over 2008 spend. This increase came after two straight years of big declines, with the biggest growth...
Major OSI shareholder calls for $60 bid
One of OSI Pharmaceuticals' major shareholders is balking at Astellas Pharma's $52-a-share tender offer for the company, saying that the Japanese drugmaker needs to raise its bid by 15 percent. And given the way OSI stock has been trading--yesterday it closed at $56.39, 8.4 percent higher than the bid--other investors...
GSK faces up to $6B Avandia liability
That U.S. Senate probe of GlaxoSmithKline and its diabetes drug Avandia may not yield any new regulatory action. But with more than 13,000 personal injury lawsuits outstanding, UBS analysts say, the company could be looking at a multibillion-dollar liability. The safety of Avandia has been open to debate for almost three...
Bioresearch Online Products
MicroFill™ Microplate Dispenser
The MicroFill™ Microplate Dispenser accommodates 96-, 384- and 24-well standard microplates and deep well blocks for bulk reagent dispensing applications....
Whether you are evaluating conventional stainless steel or single-use bioreactor systems, every bioreactor system must accomplish the same thing: control a bioprocess for an intended result. The result may be biomass, product titer, substrate conversion or any number of complex, process-specific productivity measures....
Zeta Plus EXT ZA Series Depth Filters
Filters- The new Zeta Plus EXT filters EXTends depth filtration capacity and EXTends protection of downstream membranes thereby EXTending filter life and lowering overall filtration costs. Zeta Plus EXT Series is a family of advanced dual zone depth filters designed to provide optimal clarification of bioprocess, biological and pharmaceutical fluids....
Synergy H4 Hybrid Microplate Reader
SynergyT H4 with Hybrid TechnologyT is a patent-pending multi-mode detector that combines the optical systems of Synergy Mx and Synergy 2 in one compact instrument. It is the ideal instrument for research and drug discovery applications when having to choose between flexibility and performance is not an option....
Warehouse Services by Cherokee Pharmaceuticals LLC...
Several laboratories on-site with a variety of analytical capabilities including HPLC, GC, AA, MS, NMR, NIRA, FTIR, TOC, EDXRF, Microtrac particle size, ion chromatography and UV spectrophotometer...
BeyeNETWORK Content
Confio Software Releases Ignite 8
Ignite 8 captures conventional health statistics and the more advanced response-time data and correlates these metrics to deliver unmatched perspective on the database condition and how it is affecting end user experience....
eThority Announces the Availability of eThority Enterprise Edition Version 4.0
This latest version of eThority’s flagship product offers enhanced charting and SuperPivot functionality, and also introduces new capabilities in the form of PowerFields....
DataLogix Selects Netezza TwinFin Appliance
DataLogix selected Netezza’s TwinFin data warehouse appliance to enhance its industry-leading platform....
Reinventing Business: Enterprise Data Warehouse Business Opportunities for Manufacturing, Part 1
This series of 12 articles by Allen Messerli describes an enterprise data warehouse and how it can be used to run the business, and quantifies dramatic business improvement potentials for the manufacturing industry. Part 1 begins with an overview of the series and a description and scope of the enterprise...
Bill Inmon contradicts the flawed logic of the corporate bully....
Industrial Bank Co., Ltd. Selects Teradata for Event-Based Marketing
Industrial Bank Co., Ltd. has selected the Teradata Relationship Manager (TRM) software portfolio for event-based marketing (EBM). ...
JNJ BTW
How Bridge to Employment Shapes Students’ Lives
From Imani Davis, Rutgers University Corporate Social Responsibility Fellow As part of my responsibility as the Corporate Social Responsibility Fellow, I had the opportunity to travel to Washington D.C. this past October for the 13th annual Alliance Building & Training Session (ABTS)— a professional development and networking opportunity that brought together...
More Perspectives on Text4Baby
I just had a chance to go through some of the online chatter about the announcement last week of the new Text4Baby mobile phone service that provides useful information for new and expectant moms. There are some more details on what this service means on the JNJ.com website...
White House Launches text4baby
When my son Alex was small, his baby sitter told us of a horrible personal tragedy that befell her young niece. This seemingly healthy young woman died in childbirth. As the details of the tragedy came to light it became apparent to me – and the family — that with...
Chairman and CEO Bill Weldon Highlights Johnson & Johnson’s Strategic Framework
I thought I would also highlight one other topic covered during the earnings call today. In addition to focusing on a common value system as defined by the company’s Credo, for many years, Johnson & Johnson has worked under an operating model that includes being broadly based in human...
Reflecting on the Past Two Years
At the beginning of each year, most people reflect on what they had accomplished over the previous twelve months and consider whether they met their own personal goals and expectations. Though most of us do this routinely – usually during the aftermath of New Year’s Eve – we often...
Chairman and CEO Bill Weldon Provides Additional Context on the McNeil Recall
During the earnings call earlier today, Chairman and Chief Executive Officer Bill Weldon provided some further context around the recent recall announcement by McNeil Consumer Healthcare. In his remarks to financial analysts Bill provided a more detailed account of what the investigation entailed and the complexities of identifying the...
in-PharmaTechnologist RSS
Aspen selling Brazilian plant after drop in revenues
South Africa-based Aspen Pharma is to sell its Brazilian oral solid dosage form manufacturing facility to Strides Arcolab after posting a 15 per cent drop in revenues from Latin America. ...
Synthemax cuts hESC production cost say Geron and Corning
New Synthemax synthetic growth matrix promises improved scalability for large-scale hESC production which, say developers Geron and Corning, will cut cost of cell therapy manufacture. ...
Fujifilm launches full-colour, high-res anti-counterfeiting label
Fujifilm has introduced an anti-counterfeiting label, called ForgeGuard, which it claims is the first product with full colour images and text that can be checked using a viewing device. ...
Evonik buys pharma & fine chem separations specialist MET
Evonik has bought Membrane Extraction Technology (MET), strengthening its pharma and fine chemical separation capabilities and continuing a busy week of acquisitions for the company. ...
People on the move: pharma jobs
in-PharmaTechnologist presents its latest round up of movements in the pharma sector, including a retirement at Pfizer, a new CEO at B-MS and appointments at Mylan, Archimedes and Kinex. ...
Astellas' go to courts in $3.5bn pursuit of OSI
Reports suggest that Japanese drugmaker Astellas Pharma has gone to the US courts to prevent takeover target OSI Pharmaceuticals from impeding its efforts just days after it tabled its $3.5bn (€2.5bn) bid. ...
Pharma Industry / Biotech Industry News From Medical News Today
Poniard Pharmaceuticals, Inc. (Nasdaq: PARD), a biopharmaceutical company focused on innovative oncology therapies, announced the presentation of positive final data, including survival data, from the Company's Phase 2 clinical trial of picoplatin as a first-line therapy in men with metastatic castration-resistant (hormone-refractory) prostate cancer (CRPC)......
Specialty pharmaceutical company LEO Pharma announced that findings from a Phase III study evaluating PEP005 (ingenol mebutate) Gel 0.05% to treat actinic keratosis (AK), a common pre-cursor to skin cancer, were presented at the 68th Annual Meeting of the American Academy of Dermatology (AAD) (Scientific Session Poster Discussion: P105)......
FDA Approves Name Change For Heartburn Drug Kapidex
The U.S. Food and Drug Administration has approved a name change for the heartburn drug Kapidex (dexlansoprazole) to avoid confusion with two other medications - Casodex and Kadian. Effective in late April 2010, Takeda Pharmaceuticals North America Inc. will market Kapidex under the new name Dexilant......
2010 BIO International Convention Expected To Bring More Than $25 Million To Chicago
The Biotechnology Industry Organization announced that the 2010 BIO International Convention is expected to contribute more than $25 million to the local economy, according to estimates from the Chicago Convention and Tourism Bureau. The BIO International Convention returns to Chicago May 3-6 and is expected to draw 15,000 to 17,000...
Cell Therapeutics, Inc. ("CTI") (Nasdaq and MTA: CTIC) announced that CTI received a statement on March 1, 2010 from the Gynecologic Oncology Group (GOG) leadership that the phase III GOG-212 clinical trial of CTI's OPAXIO™ used as maintenance therapy for ovarian cancer remains a high priority and enrollment will continue......
Medtronic Named Among World's Most Innovative Companies By MIT Technology Review
Medtronic, Inc. (NYSE: MDT) announced that it has been selected as one of Massachusetts Institute of Technology (MIT) Technology Review's 50 most innovative companies. Known as TR50, the first annual list includes companies that Technology Review believes have demonstrated superiority in inventing technology and in using it both to grow...
PharmiMike
A Conversation on Social Recruitment – How Social Media Channels are Evolving Recruitment
Interesting article from BraveNewTalent.com Related posts:Event: Social Media in Recruitment Diversity Recruitment in Pharma Related posts:Event: Social Media in Recruitment Diversity Recruitment in Pharma ...
Diversity Recruitment in Pharma
There seems to be an increasing amount of talk about diversity recruiting, and not just in pharma. By diversity recruiting I mean ensuring that you recruit a diverse range of candidates within your company. In reality this might mean that you broaden your recruitment net to include sites that, for...
Google are stepping up their “social media” integration with gMail by a new featured called Buzz. This allows interaction with your contacts and social media websites though the gMail account. In some respects it seems to be competing with Wave, but I guess its just another string to their social-bow. Related...
Gatszu’s “Recruitment Revolution”
Gatszu.com is claiming to be a fast and transparent recruitment solution and the start of a new revolution… The online recruitment marketplace that connects employers seeking talent to approved recruiters across the UK Launched in February 2010, gatszu.com, in association with The Sunday Times HR Business Network, is an online recruitment marketplace that connects...
Its like Twitter, only better…
I came across this today http://twitiq.com/ its a twitter “client”, that allows you to manage your Twitter account though an interface that is like Twitter only better. You can have multiple twitter accounts, and manage them quite well. You may prefer tweetdeck, but I think this is quite neat. No related posts. No...
I’m back from Christmas and from snowboarding in the Alps – getting used to all this snow at home now! Even managed to have a snow kiting (snowboard and kitewing) session a couple of miles from my house at the weekend. Brilliant. Related posts:Snowboarding with concrete cows? At last, Twitter is useful!...
S&R Blog
Which industry’s ads are most trusted by Americans?
If you answered pharma, then you’re right when compared only to the financial industry. But according to a new poll conducted by Harris Interactive and AdweekMedia, when compared to the soft drink, fast food, and auto industries, pharmaceuticals ads come in as least trustworthy by Americans. Of the five industries about...
Why Pharma Is Pushing Its Drug Pushers Out
New day. Same story. Source:Minyanville The pharmaceutical industry is going through a transformation — not only has it been consolidating with mega-mergers like the one between Merck (MRK) and Schering-Plough, but it’s facing a major patent cliff as the revenues from the blockbuster drugs of the 1990s fall prey to generic competition. Yet,...
What do physicians really think about Big Pharma?
According to Dr. Candida Fink’s latest blog post on PsychCentral, not highly. In what clearly wasn’t a good year for pharma in terms of reputation, Dr. Fink highlights why she will “no longer see any drug reps.” I didn’t want to hear from them, and I haven’t since. I avoid lectures...
Will medical education help to fill the credibility gap in pharma?
David H. Recht of North State Resources Inc. and Kelli Soare and Ed Leon of S+R Medical Communications discuss how credible, needs-based branded medical education can help to make the pharmaceutical industry a trusted resource for physicians once again. Source: Med Ad News Recognizing the erosion of trust physicians have in the...
Will the Mac Tablet revolutionize EMRs?
After a lull of about 6 months the Mac Tablet buzz has started to heat up again with Apple announcing its release for March. Like the iPhone before it, the medical community has started to hail the Mac Tablet as a revolutionary healthcare device, most notably for electronic medical records...
The top 10 health stories of 2009 (according to Harvard)
Via: Healthcare IT News Swine flu, health reform and restrictions on industry gifts to doctors are among the top 10 health stories identified by the Harvard Health Letter in its annual list. The Harvard University publication develops a top 10 list each year with help from doctors on its editorial board. Among the...
PharmaLittle
Reform for Raising PricesFollowing its earlier report about record-breaking increases on drug prices, the NYT today editorializes that Congress should abandon its "deal" with the drug industry, which traded industry support for healthcare reform for $80 B in price cuts, mainly to Medicare and Medicaid.http://www.nytimes.com/2009/11/18/opinion/18wed3.html?emc=tnt&tntemail1=yThe industry claims are all those...
DEVICE LOBBY TO HOUSE--SUSTAIN PREEMPTION!
In a statement released by Advamed, the medical device folks appear to be endorsing significant provisions of health-care reform as passed by the U.S. House. But they go out of their way to warn about compromising FDA preemption, framed in the code language of allowing states to create a variety...
Swine flu Vaccine - I think I'll.... nope not for me....
About the swine flu pandemic..I am sorry for people who get sick with the flu, I am deeply sorry for anyone who becomes gravely ill and for those families who have lost a loved one.At this point in time though, I am in morning over the missed opportunity we had...
600 Suits Against Medtronic Dismissed
The (Preemption) Beat Goes On.....FDA preemption in the arena of devices still rules in many cases. Here is a report about a judge in Minnesota who dismissed 600 cases against Medtronic over the Sprint Fidelis pacemaker.http://massdevice.com/news/minnesota-judge-dismisses-600-sprint-fidelis-suits-against-medtronicAs most here will know, there is a bill in Congress now that would amend...
It's Not Good-bye. It's Onward!Friends--Now that our beloved Ed Silverman and Pharmalot have returned, Pharmalittle will refine its focus.Of course, we never imagined we could be more than a small stop-over for a few people. We are glad that we have been that and had some fun along the way....
WARNING LABEL!!! Tort Reform Attached to Reform Bill
While Americans wait for a bill that will bring about health care reform, some in Congress are working to erode the rights of Americans.Ted Kennedy’s good friend, Sen.Orrin Hatch, supports tort reform and wants to make it part of a health care bill."I think that this is an important step...
Drugs.com - Daily MedNews
Gene Variant May Help Some Overcome Adversity
SUNDAY, March 7 -- The study of a link between misery and death has helped researchers identify a gene variant fostering resilience in the face of adversity. The U.S. research team focused on a gene called IL6, which is known to cause inflammation... ...
Electromagnetic Pulses May Stem Arthritic Knee Pain
SATURDAY, March 6 -- Electromagnetic pulses from a portable device can significantly reduce pain and inflammation in people suffering from osteoarthritis of the knee, a new study suggests. Researchers gave a battery-operated device to 34 people, who... ...
SATURDAY, March 6 -- The best way to give your children's teeth a healthy start is to begin dental care early in life, and the American Dental Association has tips for keeping kids' teeth in tip-top shape: Visit the dentist for regular checkups.... ...
Breast-Feeding Helps Mom Stay Slimmer Later in Life
FRIDAY, March 5 -- The benefits of breast-feeding for infants are numerous and well-known, but researchers are finding more and more that breast-feeding can be a boon to mom's health as well. In fact, the latest study on the subject suggests that... ...
Increasing Soda Consumption Fuels Rise in Diabetes, Heart Disease
FRIDAY, March 5 --Increasing consumption of sugary soft drinks contributed to 130,000 new cases of diabetes, 14,000 new cases of heart disease and 50,000 more life-years burdened with heart disease in the last decade, a new U.S. study finds. "The... ...
Processed Meat May Harm the Heart
FRIDAY, March 5 -- Conventional wisdom has dictated that fat from red meat is a risk factor for heart disease, but a new analysis from Harvard researchers finds it's eating processed meat -- not unprocessed red meat -- that increases the risk for... ...
Pharmaceutical Online Products
Basil 5700 LSR Cage And Rack Washer
The Basil 5700LSR is designed for high capacity, efficient cleaning, sanitization and drying of animal cages, racks, debris pans, feeder bottles and other miscellaneous items used in the care of laboratory animals. This innovative cage washer can be interfaced to a vaporized hydrogen peroxide generator allowing for high level decontamination...
The Industrial Business of Roche Applied Science draws on the expertise of an integrated Diagnostics, Research Biochemicals and Pharmaceuticals manufacturer....
The MHI vial filler is specially designed for clinical trials vial filling. The MHI is built to the same high standards and features of a production system, but with the lower output and small footprint needed for trials filling....
How do I move my compound to the next milestone? What types of studies will regulators require? The answers to these questions depend on your compound, its intended purpose, mode of delivery and many other variables....
Steam-Thru® II Connections provides a quick and easy sterile connection between biopharmaceutical processing equipment and single-use assemblies....
The Saturn DigiSizer II™ is the first commercially available particle sizing instrument to employ the light scattering analysis technique that utilizes advanced digital detection technology to deliver exceptionally high levels of resolution, accuracy, repeatability, and reproducibility....
Dose of Digital
Are You Reminding Me or Annoying Me?
One of the very first areas I started blogging about on Dose of Digital dealt with medication compliance. After working on compliance challenges for my final two years at AstraZeneca before moving to my current job at Bridge Worldwide, I’d seen pretty much every tactic you could...
Monitor This, Forget That — “The Monitoring Continuum”
One of the most contentious posts ever on Dose of Digital was my post about social media monitoring for pharma and healthcare. The title alone was enough to set some people off: Pharma Should Forget About Social Media Monitoring. The point of that post was not that everyone should truly...
The Seven Uses of Social Media in Business — The 7 “C”s
Whether it be healthcare or any other industry, different companies have come up with and rely on different uses of social media to meet their brand objectives. After surveying a bunch of different social media programs (including the hundreds found on the Pharma and Healthcare Social Media Wiki), I figured...
The Best Pharma Products According to Patients
UPDATE (Feb. 2, 2010): Based on some feedback from none other than John Mack, I’ve changed a couple of pieces of info from my original post, as well as some insights from iGuard about how they conduct their surveys. This can be found at the bottom of this post.] On a...
How Google and Bing Plan to Eliminate the Need for WebMD (and Your Website)
Those of you who are regular readers know that I’m a big believer in search optimization. In most cases, it’s the single most powerful way to expose the right people to your brand at the right time. The importance of search as it relates to our digital lives is pretty...
Social Media in Pharma and Healthcare 2010: First Wiki Update of the Year
For those of you who are really interested in social media in pharma and healthcare, 2009 was a banner year for you. Literally hundreds of new programs were launched, as companies became more comfortable with the idea that it’s possible to use social media in pharma and healthcare. I like to...
Pharma Blog Review
Yes, the Pharma Blog Week in Review is back. I had to take a break from it over the holidays; I even became so silent on Twitter that I had a few folks ask me if I was all right. But I knew I’d get back into the swing of...
It’s a mixed bag this week in pharma industry news (much like that sack of your kids hauled home from their trick-or-treating, for every KitKat, there’s a bag of candy corn). Some of the notable items: Johnson & Johnson announced the company would be reducing its headcount by...
For Halloween, some bloggy treats (no tricks)
Halloween is tomorrow, but for the pharmaceutical industry, the real “party” will be November’s two-day meeting on social media use, sponsored by FDA. Everyone is hoping the hearing will yield a treat (in the form of a workable guidance on social media) and not tricks (in the form of FDA...
Pharma still uneasy about getting social
This week was full and frantically busy, and I am not just talking about the three days I drove back and forth to Bridgewater, N.J., for ExL Pharma’s Digital Pharma conference (if you want the quick lowdown on what happened there, you can find the Tweets, from me and many...
Pfizer pfuels burst of blogger speculation
The week ended in a big way, as Pfizer’s acquisition of Wyeth became final and FDA approved GlaxoSmithKline’s Cervarix vaccine for cervical cancer. Also, debate continued about the healthcare reform bill passed by the Senate Finance Committee last week. And fortunately for the industry, no recent bombs about ghostwriting or...
Now that I’m back in the office from my Boston vacation (and a very interesting visit last Monday with Jeff Porter, Tim Wright, and Mark Fishman of Novartis Institutes for Biomedical Research, which I will be writing about in January’s R&D Directions), I have some stuff to catch up on....
Drugs.com - FDA MedWatch Alerts
Voltaren Gel (diclofenac sodium topical gel) 1% - Hepatic Effects Labeling Changes
Audience: Rheumatological healthcare professionals, pharmacists Endo, Novartis and FDA notified healthcare professionals of revisions to the Hepatic Effects section of the prescribing information to add new warnings and precautions about the... ...
Lexiva (fosamprenavir calcium) - Dear Healthcare Professional Letter
Audience: HIV/Infectious Disease healthcare professionals, cardiovascular healthcare professionals GlaxoSmithKline and FDA notified healthcare professionals of a potential association between Lexiva and myocardial infarction and dyslipidemia in HIV... ...
Valproate Sodium and related products (valproic acid and divalproex sodium): Risk of Birth Defects
Audience: Neurological and Obstetrical healthcare professionals The FDA notified health care professionals and patients about the increased risk of neural tube defects and other major birth defects, such as craniofacial defects and cardiovascular... ...
Norpramin (desipramine hydrochloride) - Dear Healthcare Professional Letter
Audience: Psychiatric healthcare professionals Sanofi-Aventis and FDA notified healthcare professionals of changes to the Warnings and Overdosage sections of the Prescribing Information for Norpramin (desipramine hydrochloride), indicated for the... ...
Meridia (sibutramine hydrochloride): Early Communication about an Ongoing Safety Review
Audience: Cardiology and endocrinology healthcare professionals FDA notified healthcare professionals and patients that it is reviewing preliminary data from a recent study suggesting that patients using sibutramine have a higher number of... ...
Vicks Sinex Nasal Spray - Recall
Audience: Consumers Procter & Gamble and FDA notified consumers of a voluntary recall of three lots of Vicks Sinex Nasal Spray in the United States, Germany and the United Kingdom. The bacteria B. cepacia was found in a small amount of... ...